Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study

by Ilaria J Chicca, Jennifer LJ Heaney, Gulnaz Iqbal, Janet A Dunn, Stella Bowcock, Tim Planche, Guy Pratt, Kwee Yong, Eric Low, Jill Wood, Kerry Raynes, Helen Higgins, Mark T Drayson
Published 2020-12-01

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

by Mark T Drayson, Stella Bowcock, Tim Planche, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Jill Wood, Kerry Raynes, Helen Higgins, Bryony Dawkins, David Meads, Claire T Hulme, Anna C Whittaker, Peter Hawkey, Eric Low, Janet A Dunn
Published 2019-11-01

Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs

by Spyros Kolovos, Guido Nador, Bhuvan Kishore, Matthew Streetly, Neil K. Rabin, Andrew D Chantry, Kwee Yong, John Ashcroft, Stella Bowcock, Mark T. Drayson, Karthik Ramasamy, Daniel Prieto-Alhambra, Cyrus Cooper, M. Kassim Javaid, Rafael Pinedo-Villanueva
Published 2019-08-01